Literature DB >> 21372593

Blood loss related to participation in pharmacokinetic study in preterm neonates.

Lenne-Triin Heidmets1, Tuuli Metsvaht, Mari-Liis Ilmoja, Heti Pisarev, Kersti Oselin, Irja Lutsar.   

Abstract

BACKGROUND: The amount of blood that can be safely drawn from a preterm neonate for scientific purposes is poorly established.
OBJECTIVES: To provide scientific evidence on the amount of blood that can be drawn from very low birth weight (VLBW) neonates for study purposes.
METHODS: We performed a post-hoc analysis of a pharmacokinetic (PK) study of penicillin-G, enrolling 18 neonates with a birth weight of <1,200 g, gestational age of <28 weeks and postnatal age of <5 days, with a risk of early onset sepsis. A median of 2.3 ml/kg of blood was collected from each neonate for the PK analysis. Hemoglobin (Hgb), hematocrit (Ht), basic hemodynamic parameters, total fluid intake, number of blood component transfusions and number of blood analysis for clinical indications were recorded. The control group consisted of 35 gestational age-, postnatal age- and birth weight-matched neonates who had not participated in a PK study.
RESULTS: We did not observe significant differences in any studied safety parameter, including Hgb and Ht values, between the two groups. Median number of blood component transfusions (n = 2 in both groups), median volume of transfused red blood cells (22 vs. 24 ml/kg in study vs. control group) and total daily fluid requirement were similar. The median calculated blood loss on clinical indications was 1.9 ml/24 h in the control group and 1.66 ml/24 h in the study group.
CONCLUSIONS: In VLBW neonates, up to 2.3 ml/kg of blood (corresponding to 2.4% of calculated circulating blood volume) can be drawn for scientific purposes without compromising basic hemodynamic parameters, Hgb and Ht values, blood component transfusions or fluid requirements.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21372593     DOI: 10.1159/000323699

Source DB:  PubMed          Journal:  Neonatology        ISSN: 1661-7800            Impact factor:   4.035


  4 in total

Review 1.  Clinical trials of medicines in neonates: the influence of ethical and practical issues on design and conduct.

Authors:  Mark A Turner
Journal:  Br J Clin Pharmacol       Date:  2015-03       Impact factor: 4.335

2.  Meropenem vs standard of care for treatment of late onset sepsis in children of less than 90 days of age: study protocol for a randomised controlled trial.

Authors:  Irja Lutsar; Ursula M T Trafojer; Paul T Heath; Tuuli Metsvaht; Joseph Standing; Susanna Esposito; Vincent Meiffredy de Cabre; Clarissa Oeser; Jean-Pierre Aboulker
Journal:  Trials       Date:  2011-09-30       Impact factor: 2.279

3.  The CLOSED trial; CLOnidine compared with midazolam for SEDation of paediatric patients in the intensive care unit: study protocol for a multicentre randomised controlled trial.

Authors:  Antje Neubert; Manuel Alberto Baarslag; Monique van Dijk; Joost van Rosmalen; Joseph F Standing; Yucheng Sheng; Wolfgang Rascher; Deborah Roberts; Jackie Winslade; Louise Rawcliffe; Sara M Hanning; Tuuli Metsvaht; Viviana Giannuzzi; Peter Larsson; Pavla Pokorná; Alessandra Simonetti; Dick Tibboel
Journal:  BMJ Open       Date:  2017-06-21       Impact factor: 2.692

4.  Pharmacometric Analysis of Intranasal and Intravenous Nalbuphine to Optimize Pain Management in Infants.

Authors:  Miriam Pfiffner; Eva Berger-Olah; Priska Vonbach; Marc Pfister; Verena Gotta
Journal:  Front Pediatr       Date:  2022-03-02       Impact factor: 3.418

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.